Literature DB >> 1760766

Calcium absorption in normal and osteoporotic postmenopausal women.

H A Morris1, A G Need, M Horowitz, P D O'Loughlin, B E Nordin.   

Abstract

Hourly fractional absorption of radiocalcium (alpha), serum calcitriol, and a number of other variables were measured in 152 normal and 148 osteoporotic postmenopausal women. Alpha, body weight, and serum albumin were all significantly lower in the osteoporotic than in the normal women, and plasma alkaline phosphatase, fasting urinary calcium, sodium, and hydroxyproline were all significantly higher in the osteoporotic than in the normal group. The most significant determinant of alpha in each group was the serum calcitriol concentration, but calcium absorption relative to serum calcitriol was significantly lower in the osteoporotic than in the normal women. The serum calcitriol level was slightly but not significantly lower in the osteoporotic than in the normal group and accounted for only 20% of the difference in alpha between them. The implied "resistance" to calcitriol in the osteoporotic group was significantly related to serum albumin and body weight but independent of age. Urinary hydroxyproline was an inverse function of alpha and a positive function of fasting urinary calcium in the osteoporotic group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1760766     DOI: 10.1007/bf02556211

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  14 in total

Review 1.  The rapid, hormonally stimulated transport of calcium (transcaltachia)

Authors:  I Nemere; A W Norman
Journal:  J Bone Miner Res       Date:  1987-06       Impact factor: 6.741

2.  Improved method for calculating calcium fractions in plasma: reference values and effect of menopause.

Authors:  B E Nordin; A G Need; T F Hartley; J C Philcox; M Wilcox; D W Thomas
Journal:  Clin Chem       Date:  1989-01       Impact factor: 8.327

3.  Malabsorption of calcium in corticosteroid-induced osteoporosis.

Authors:  H A Morris; A G Need; P D O'Loughlin; M Horowitz; A Bridges; B E Nordin
Journal:  Calcif Tissue Int       Date:  1990-05       Impact factor: 4.333

4.  Biochemical effects of a calcium supplement in osteoporotic postmenopausal women with normal absorption and malabsorption of calcium.

Authors:  A G Need; M Horowitz; J C Philcox; B E Nordin
Journal:  Miner Electrolyte Metab       Date:  1987

5.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.

Authors:  J C Gallagher; B L Riggs; J Eisman; A Hamstra; S B Arnaud; H F DeLuca
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

6.  Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.

Authors:  M Horowitz; A G Need; J C Philcox; B E Nordin
Journal:  Am J Clin Nutr       Date:  1984-06       Impact factor: 7.045

7.  A comparison of radioactive calcium absorption tests with net calcium absorption.

Authors:  D H Marshall; B E Nordin
Journal:  Clin Sci (Lond)       Date:  1981-10       Impact factor: 6.124

8.  Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis.

Authors:  R M Francis; M Peacock
Journal:  Am J Clin Nutr       Date:  1987-08       Impact factor: 7.045

9.  Purification of plasma vitamin D metabolites for radioimmunoassay.

Authors:  G A Taylor; M Peacock; B Pelc; W Brown; A Holmes
Journal:  Clin Chim Acta       Date:  1980-12-08       Impact factor: 3.786

10.  Thiazide effect on the mineral content of bone.

Authors:  R D Wasnich; R J Benfante; K Yano; L Heilbrun; J M Vogel
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

View more
  14 in total

Review 1.  Should the treatment of osteoporosis be more selective?

Authors:  B E Christopher Nordin
Journal:  Osteoporos Int       Date:  2003-03-12       Impact factor: 4.507

2.  Intestinal calcium absorption from different calcium preparations: influence of anion and solubility.

Authors:  C Hansen; E Werner; H J Erbes; V Larrat; J P Kaltwasser
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

3.  Effects of Ulmus davidiana planch on mineralization, bone morphogenetic protein-2, alkaline phosphatase, type I collagen, and collagenase-1 in bone cells.

Authors:  Sung-Koo Kang; Kap-Sung Kim; Yu-Seok Byun; Seok-Jong Suh; Un-Ho Jim; Kyung-Ho Kim; In-Seon Lee; Cheorl-Ho Kim
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

Review 4.  The calcium controversy.

Authors:  B E Nordin
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

5.  Vitamin D: a hormone for all seasons--how much is enough?

Authors:  Howard A Morris
Journal:  Clin Biochem Rev       Date:  2005-02

6.  Correlates of intestinal calcium absorption in women 10 years past the menopause.

Authors:  A Devine; R L Prince; D A Kerr; I M Dick; R A Criddle; G N Kent; R I Price; P G Webb
Journal:  Calcif Tissue Int       Date:  1993-05       Impact factor: 4.333

7.  Radiocalcium absorption is reduced in postmenopausal women with vertebral and most types of peripheral fractures.

Authors:  B E Christopher Nordin; Peter D O'Loughlin; Allan G Need; Michael Horowitz; Howard A Morris
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

8.  Effect of 17beta-oestradiol on transepithelial calcium transport in human intestinal-like Caco-2 cells and its interactions with 1,25-dihydroxycholecalciferol and 9-cis retinoic acid.

Authors:  A A Cotter; Kevin D Cashman
Journal:  Eur J Nutr       Date:  2006-02-20       Impact factor: 5.614

Review 9.  Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

Authors:  K L Dechant; K L Goa
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

10.  Vitamin D metabolism: new concepts and clinical implications.

Authors:  P H Anderson; B K May; H A Morris
Journal:  Clin Biochem Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.